10-Q Filing

ST JUDE MEDICAL INC CIK: 203077 Q1 2015

Filing Information

Form Type	10-Q
Accession Number	`0000203077-15-000005`
Period End Date	20150331
Filing Date	20150507
Fiscal Year	2015
Fiscal Period	Q1
XBRL Instance	stj-20150404.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 88 Income Statement 48 Cash Flow Statement 60 Comprehensive Income 17

Balance Sheet 88 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$52.00M	USD	Point-in-time
Accounts receivable allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$53.00M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.44B	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$1.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.45B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$695.00M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.37B	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$1.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Accounts receivable, less allowance for doubtful accounts of $52 million and $53 million at April 4, 2015 and January 3, 2015, respectively	`AccountsReceivableNetCurrent`	$1.19B	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Accounts receivable, less allowance for doubtful accounts of $52 million and $53 million at April 4, 2015 and January 3, 2015, respectively	`AccountsReceivableNetCurrent`	$1.22B	USD	Point-in-time
Finished goods	`InventoryFinishedGoodsNetOfReserves`	$543.00M	USD	Point-in-time
Preferred Stock Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred Stock Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Finished goods	`InventoryFinishedGoodsNetOfReserves`	$536.00M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Work in process	`InventoryWorkInProcessNetOfReserves`	$82.00M	USD	Point-in-time
Work in process	`InventoryWorkInProcessNetOfReserves`	$77.00M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Raw materials	`InventoryRawMaterialsNetOfReserves`	$164.00M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Raw materials	`InventoryRawMaterialsNetOfReserves`	$190.00M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	286.66M	shares	Point-in-time
Inventories	`InventoryNet`	$784.00M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	280.20M	shares	Point-in-time
Inventories	`InventoryNet`	$808.00M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$496.00M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	286.66M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	280.20M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$473.00M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$3.19B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$3.91B	USD	Point-in-time
Property, plant and equipment, at cost	`PropertyPlantAndEquipmentGross`	$2.74B	USD	Point-in-time
Property, plant and equipment, at cost	`PropertyPlantAndEquipmentGross`	$2.77B	USD	Point-in-time
Less: Accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$1.43B	USD	Point-in-time
Less: Accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$1.43B	USD	Point-in-time
Net property, plant and equipment	`PropertyPlantAndEquipmentNet`	$1.34B	USD	Point-in-time
Net property, plant and equipment	`PropertyPlantAndEquipmentNet`	$1.31B	USD	Point-in-time
Goodwill	`Goodwill`	$3.53B	USD	Point-in-time
Goodwill	`Goodwill`	$3.51B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$825.00M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$851.00M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$579.00M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$567.00M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$10.21B	USD	Point-in-time
TOTAL ASSETS	`Assets`	$9.41B	USD	Point-in-time
Current debt obligations	`DebtCurrent`	$1.74B	USD	Point-in-time
Current debt obligations	`DebtCurrent`	$1.59B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$208.00M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$151.00M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$60.00M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$72.00M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$749.00M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$862.00M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.67B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.77B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$1.77B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$2.27B	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$1.02B	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$999.00M	USD	Point-in-time
Total liabilities	`Liabilities`	$5.53B	USD	Point-in-time
Total liabilities	`Liabilities`	$5.96B	USD	Point-in-time
Commitments and Contingencies (Note 4)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 4)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock ($1.00 par value; 25,000,000 shares authorized; none outstanding)	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock ($1.00 par value; 25,000,000 shares authorized; none outstanding)	`PreferredStockValue`	-	USD	Point-in-time
Common stock ($0.10 par value; 500,000,000 shares authorized; 280,199,780 and 286,659,901 shares issued and outstanding at April 4, 2015 and January 3, 2015, respectively)	`CommonStockValueOutstanding`	$28.00M	USD	Point-in-time
Common stock ($0.10 par value; 500,000,000 shares authorized; 280,199,780 and 286,659,901 shares issued and outstanding at April 4, 2015 and January 3, 2015, respectively)	`CommonStockValueOutstanding`	$29.00M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$118.00M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$10.00M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$4.22B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$4.08B	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-173.00M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$56.00M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-270.00M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$46.00M	USD	Point-in-time
Total shareholders' equity before noncontrolling interest	`StockholdersEquity`	$3.84B	USD	Point-in-time
Total shareholders' equity before noncontrolling interest	`StockholdersEquity`	$4.20B	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$39.00M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$45.00M	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.24B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.88B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.40B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.23B	USD	Point-in-time
TOTAL LIABILITIES AND SHAREHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$9.41B	USD	Point-in-time
TOTAL LIABILITIES AND SHAREHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$10.21B	USD	Point-in-time

Income Statement 48 line items

Line Item	Tag	Value	Unit	Period
Net sales	`SalesRevenueNet`	$1.36B	USD	1 Quarter
Net sales	`SalesRevenueNet`	$1.34B	USD	1 Quarter
Cost of sales before special charges	`CostOfSalesBeforeSpecialCharges`	$393.00M	USD	1 Quarter
Cost of sales before special charges	`CostOfSalesBeforeSpecialCharges`	$382.00M	USD	1 Quarter
Special charges	`SpecialCharges`	$1.00M	USD	1 Quarter
Special charges	`SpecialCharges`	$2.00M	USD	1 Quarter
Total cost of sales	`CostOfGoodsSold`	$395.00M	USD	1 Quarter
Total cost of sales	`CostOfGoodsSold`	$383.00M	USD	1 Quarter
Gross profit	`GrossProfit`	$980.00M	USD	1 Quarter
Gross profit	`GrossProfit`	$950.00M	USD	1 Quarter
Selling, general and administrative expense	`SellingGeneralAndAdministrativeExpense`	$444.00M	USD	1 Quarter
Selling, general and administrative expense	`SellingGeneralAndAdministrativeExpense`	$430.00M	USD	1 Quarter
Research and development expense	`ResearchAndDevelopmentExpense`	$167.00M	USD	1 Quarter
Research and development expense	`ResearchAndDevelopmentExpense`	$170.00M	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$24.00M	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$21.00M	USD	1 Quarter
Special charges	`RestructuringSettlementAndImpairmentProvisions`	$33.00M	USD	1 Quarter
Special charges	`RestructuringSettlementAndImpairmentProvisions`	$4.00M	USD	1 Quarter
Operating profit	`OperatingIncomeLoss`	$312.00M	USD	1 Quarter
Operating profit	`OperatingIncomeLoss`	$325.00M	USD	1 Quarter
Interest income	`InterestIncome`	$1.00M	USD	1 Quarter
Interest income	`InterestIncome`	$1.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$21.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$21.00M	USD	1 Quarter
Other (income) expense	`Otherincomeexpense`	-	USD	1 Quarter
Other (income) expense	`Otherincomeexpense`	$3.00M	USD	1 Quarter
Other expense, net	`OtherNonoperatingIncomeExpense`	$-17.00M	USD	1 Quarter
Other expense, net	`OtherNonoperatingIncomeExpense`	$-20.00M	USD	1 Quarter
Earnings before income taxes and noncontrolling interest	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$308.00M	USD	1 Quarter
Earnings before income taxes and noncontrolling interest	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$292.00M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$52.00M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$53.00M	USD	1 Quarter
Net earnings before noncontrolling interest	`ProfitLoss`	$239.00M	USD	1 Quarter
Net earnings before noncontrolling interest	`ProfitLoss`	$256.00M	USD	1 Quarter
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-6.00M	USD	1 Quarter
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-10.00M	USD	1 Quarter
Net earnings attributable to St. Jude Medical, Inc.	`NetIncomeLoss`	$249.00M	USD	1 Quarter
Net earnings attributable to St. Jude Medical, Inc.	`NetIncomeLoss`	$262.00M	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.93	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.88	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.91	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.86	USD	1 Quarter
Cash dividends declared per share:	`CommonStockDividendsPerShareDeclared`	$0.27	USD	1 Quarter
Cash dividends declared per share:	`CommonStockDividendsPerShareDeclared`	$0.29	USD	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	283.00M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	284.40M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	287.10M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	289.30M	shares	1 Quarter

Cash Flow Statement 60 line items

Line Item	Tag	Value	Unit	Period
Net earnings before noncontrolling interest	`ProfitLoss`	$239.00M	USD	1 Quarter
Net earnings before noncontrolling interest	`ProfitLoss`	$256.00M	USD	1 Quarter
Depreciation of property, plant and equipment	`Depreciation`	$54.00M	USD	1 Quarter
Depreciation of property, plant and equipment	`Depreciation`	$55.00M	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$24.00M	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$21.00M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$17.00M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$17.00M	USD	1 Quarter
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$16.00M	USD	1 Quarter
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$-13.00M	USD	1 Quarter
Other, net	`OtherOperatingActivitiesCashFlowStatement`	$-32.00M	USD	1 Quarter
Other, net	`OtherOperatingActivitiesCashFlowStatement`	$-8.00M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-67.00M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$47.00M	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$65.00M	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$46.00M	USD	1 Quarter
Other current and noncurrent assets	`IncreaseDecreaseInOtherOperatingAssets`	$-13.00M	USD	1 Quarter
Other current and noncurrent assets	`IncreaseDecreaseInOtherOperatingAssets`	$-2.00M	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-103.00M	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-6.00M	USD	1 Quarter
Income taxes payable	`IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable`	$25.00M	USD	1 Quarter
Income taxes payable	`IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable`	$21.00M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$273.00M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$234.00M	USD	1 Quarter
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$33.00M	USD	1 Quarter
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$46.00M	USD	1 Quarter
Proceeds from sale of investments	`ProceedsFromSaleOfAvailableForSaleSecuritiesEquity`	-	USD	1 Quarter
Proceeds from sale of investments	`ProceedsFromSaleOfAvailableForSaleSecuritiesEquity`	$4.00M	USD	1 Quarter
Other investing activities, net	`PaymentsForProceedsFromOtherInvestingActivities`	$1.00M	USD	1 Quarter
Other investing activities, net	`PaymentsForProceedsFromOtherInvestingActivities`	-	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-34.00M	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-42.00M	USD	1 Quarter
Proceeds from exercise of stock options and stock issued, net	`ProceedsFromStockOptionsExercised`	$38.00M	USD	1 Quarter
Proceeds from exercise of stock options and stock issued, net	`ProceedsFromStockOptionsExercised`	$60.00M	USD	1 Quarter
Excess tax benefits from stock issued under employee stock plans	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$5.00M	USD	1 Quarter
Excess tax benefits from stock issued under employee stock plans	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$9.00M	USD	1 Quarter
Common stock repurchased, including related costs	`PaymentsForRepurchaseOfCommonStock`	$476.00M	USD	1 Quarter
Common stock repurchased, including related costs	`PaymentsForRepurchaseOfCommonStock`	$500.00M	USD	1 Quarter
Dividends paid	`PaymentsOfDividends`	$72.00M	USD	1 Quarter
Dividends paid	`PaymentsOfDividends`	$77.00M	USD	1 Quarter
Issuances (payments) of commercial paper borrowings, net	`ProceedsFromRepaymentsOfShortTermDebt`	$326.00M	USD	1 Quarter
Issuances (payments) of commercial paper borrowings, net	`ProceedsFromRepaymentsOfShortTermDebt`	$390.00M	USD	1 Quarter
Payments under debt facilities	`RepaymentsOfLongTermDebt`	$750.00M	USD	1 Quarter
Payments under debt facilities	`RepaymentsOfLongTermDebt`	-	USD	1 Quarter
Other financing activities, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-6.00M	USD	1 Quarter
Other financing activities, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-6.00M	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-900.00M	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-159.00M	USD	1 Quarter
Effect of currency exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-47.00M	USD	1 Quarter
Effect of currency exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$1.00M	USD	1 Quarter
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$73.00M	USD	1 Quarter
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-747.00M	USD	1 Quarter
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.44B	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.45B	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$695.00M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.37B	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.45B	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$695.00M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.44B	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.37B	USD	Point-in-time

Comprehensive Income 17 line items

Line Item	Tag	Value	Unit	Period
Tax expense (benefit) on related to increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax`	$5.00M	USD	1 Quarter
Net earnings before noncontrolling interest	`ProfitLoss`	$239.00M	USD	1 Quarter
Net earnings before noncontrolling interest	`ProfitLoss`	$256.00M	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	-	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$1.00M	USD	1 Quarter
Unrealized gain (loss) on derivative financial instruments, net of taxes of $5 million	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	-	USD	1 Quarter
Unrealized gain (loss) on derivative financial instruments, net of taxes of $5 million	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	$29.00M	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-127.00M	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$10.00M	USD	1 Quarter
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-97.00M	USD	1 Quarter
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$10.00M	USD	1 Quarter
Total comprehensive income before noncontrolling interest	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$159.00M	USD	1 Quarter
Total comprehensive income before noncontrolling interest	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$249.00M	USD	1 Quarter
Total comprehensive loss attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-6.00M	USD	1 Quarter
Total comprehensive loss attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-10.00M	USD	1 Quarter
Total comprehensive income attributable to St. Jude Medical, Inc.	`ComprehensiveIncomeNetOfTax`	$259.00M	USD	1 Quarter
Total comprehensive income attributable to St. Jude Medical, Inc.	`ComprehensiveIncomeNetOfTax`	$165.00M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.